📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
AARTI PHARMALABS LIMITEDAARTIPHARMPharmaceuticals
Open
744.3
High
746.95
Low
709
Close
713.2
Volume
396512
Exchange
nse
Time
14-Nov-2025

Outlook

Score:

0

Rating:

RISKY

Candlestick Pattern

CandlepatternofAartiPharmalabsis
Opening Marubozu
EstimatedStoplossofAartiPharmalabsis
746.95
AartiPharmalabshasa
Bearishℹ
pattern.
Formationof
Opening Marubozu
candlepatternindicatesAartiPharmalabshaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

AartiPharmalabsisin
Downtrendℹ
.
PriceofAartiPharmalabsis
Downℹ
by

14.59

%.
Target
Buy@

709

Sell@

840.55

Current@

713.2

Volume

ThetradesofAartiPharmalabshavebeenin
Immenseℹ
volume.
ThevolumetradesforAartiPharmalabsare
Bearishℹ
with
Strong Sellersℹ
ThetradevolumeofAartiPharmalabsis

Up

by

66.09

%

Valuation

ThecurrentmarketpriceofAartiPharmalabsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth2906crandtotalassetsworth2906cr,thebalancesheetofAartiPharmalabsis:
Balancedℹ
.
Cashflow
AartiPharmalabshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 16cr

.Itis
Downℹ
by

245.45

%.
40.91% i.e. ₹ 331cr earned in operatingℹ
51.05% i.e. ₹ 413cr spent in investingℹ
8.03% i.e. ₹ 65cr earned in financingℹ
0% in otherℹ
AartiPharmalabshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 11cr

.Itis
Upℹ
by

118.97

%.
49.2% i.e. ₹ 216cr earned in operatingℹ
48.75% i.e. ₹ 214cr spent in investingℹ
2.05% i.e. ₹ 9cr earned in financingℹ
0% in otherℹ
Income
TheincomeofAartiPharmalabsis

₹ 418cr

and

Profit

is:

₹ 28cr

AartiPharmalabsProfitisdownby:

42.05

%andIncomeisDownby:

31.14

%
TheincomeofAartiPharmalabsis

₹ 387cr

and

Profit

is:

₹ 51cr

AartiPharmalabsProfitisupby:

20.55

%andIncomeisUpby:

3.69

%
TheincomeofAartiPharmalabsis

₹ 562cr

and

Profit

is:

₹ 88cr

AartiPharmalabsProfitisupby:

35.19

%andIncomeisUpby:

17.32

%
By using this site you agree to the use of cookies to deliver a better site experience.